Lenz M, Rétey J
Department of Biochemistry, University of Karlsruhe, Germany.
Eur J Biochem. 1993 Oct 1;217(1):429-34. doi: 10.1111/j.1432-1033.1993.tb18262.x.
The histidine-utilizing hutU gene was isolated from a lambda-EMBL3 phage of a genomic library from Pseudomonas putida nicII and subcloned into the expression vector pT7-7. Escherichia coli BL21 cells were transformed with the recombinant plasmid and produced a catalytically active protein, amounting to approximately 30% of the total protein in the crude cell-free extract. The addition of NAD+ to the growth medium ensured the full occupation of active sites by the cofactor. This requires a mechanism for the transport of NAD+ into E. coli cells. Using the overproducing mutant a new, fast and efficient isolation procedure is described which yields electrophoretically homogeneous urocanase within two days. The yield of pure enzyme, based on the culture volume, has been improved 50-80-fold compared with the traditional method. To investigate the possible role of cysteine residues in the catalysis or in the tight binding of the cofactor NAD+, six different mutants were prepared. In each mutant protein, one conserved cysteine was exchanged for alanine. The resulting clones were tested for the expression of urocanase with catalytic activity; the Km and Vmax values were determined. Only Cys410 was essential for catalysis. There was no detectable reconstitution or increase of activity after the addition of NAD+, either in the essential Cys/Ala mutant or the other mutant proteins. Electrospray-mass spectroscopy of the wild-type enzyme revealed that the coenzyme is not covalently bound to the protein and computational analysis showed no typical sequence for a mononucleotide-binding domain like the Rossman fold. To obtain urocanase apoenzyme, P. putida nicII was transformed with pGP1-2 and pTET7-U and grown in nicotinate-depleted medium. Like the mutant proteins, no activation of the apoform occurred after the addition of NAD+. These observations led us to postulate a new model for the non-covalent but tight binding of NAD+ to the enzyme by 'trapping' the cofactor while folding the nascent protein.
利用组氨酸的hutU基因是从恶臭假单胞菌nicII基因组文库的λ-EMBL3噬菌体中分离出来的,并亚克隆到表达载体pT7-7中。用重组质粒转化大肠杆菌BL21细胞,产生了一种具有催化活性的蛋白质,其含量约占粗无细胞提取物中总蛋白的30%。向生长培养基中添加NAD +可确保辅因子完全占据活性位点。这需要一种将NAD +转运到大肠杆菌细胞中的机制。使用过量生产突变体,描述了一种新的、快速且高效的分离程序,该程序可在两天内产生电泳纯的尿刊酸酶。与传统方法相比,基于培养体积的纯酶产量提高了50至80倍。为了研究半胱氨酸残基在催化或辅因子NAD +紧密结合中的可能作用,制备了六个不同的突变体。在每个突变蛋白中,一个保守的半胱氨酸被替换为丙氨酸。测试所得克隆是否表达具有催化活性的尿刊酸酶;测定Km和Vmax值。只有Cys410对催化至关重要。在必需的Cys/Ala突变体或其他突变蛋白中,添加NAD +后均未检测到活性的重建或增加。野生型酶的电喷雾质谱分析表明,辅酶不与蛋白质共价结合,计算分析未显示出像Rossman折叠那样的单核苷酸结合域的典型序列。为了获得尿刊酸酶脱辅酶,用pGP1-2和pTET7-U转化恶臭假单胞菌nicII,并在烟酸耗尽的培养基中生长。与突变蛋白一样,添加NAD +后脱辅基形式未发生激活。这些观察结果使我们推测出一种新模型,即通过在新生蛋白质折叠时“捕获”辅因子,使NAD +与酶非共价但紧密结合。